Reported positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 demonstrating dose-dependent decreases ...

Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type ...

Hartford High Yield Fund (I Share) underperformed Bloomberg US Corporate High Yield Bond Index during the quarter. Read more ...

Colleen Rooney looked in good spirits as she departed the gym in Cheshire on Tuesday morning as she filmed her new Disney ...

“Anybody who knows Gaurav loved him, and knew he was the boy with the biggest smile and the biggest hug,” Madan, who is in ...

The tech company is rolling out a completely revamped version of its app with unique experiences and services, and social ...

Initiated dosing of participants in the first-in-human study of ABS-101 (anti-TL1A antibody), with interim data expected in the second half of 2025 ABS-201 (anti-PRLR) non-human primate (NHP) data ...

Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment optionsPhase II data show ...

Meaningful extension of cash runway guidance from H2 2027 to H2 2028 following strategic decision to pursue partnership opportunities for naporafenib SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Erasca ...

Willem Duursma is holding off the pack as the top prospect in 2025, but a Fremantle NGA prospect has burst into the top 10, ...

I rank players using the FV system so you can see where they'd slot into your team's prospect list or a full MLB top 100 ...

BofA Securities 2025 Healthcare Conference May 13, 2025 1:40 PM ETCompany ParticipantsJohn Reed - Executive Vice ...